tiprankstipranks
INOVIQ Ltd Advances Breast Cancer Detection Test
Company Announcements

INOVIQ Ltd Advances Breast Cancer Detection Test

Inoviq Ltd (AU:IIQ) has released an update.

Don't Miss Our Christmas Offers:

INOVIQ Ltd has successfully completed disease specificity testing for its new breast cancer blood test, showcasing its ability to accurately detect breast cancer with 81% sensitivity and 93% specificity. The test outperforms existing FDA-approved tests by reducing false positives and is being developed for the US market as a laboratory-developed test. This advancement positions INOVIQ as a key player in the breast cancer diagnostics market, with plans to expand its technology to other cancer biomarkers.

For further insights into AU:IIQ stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskINOVIQ Breakthrough in Exosome Cancer Therapy
TipRanks Australian Auto-Generated NewsdeskInoviq Ltd Unveils Breakthrough Ovarian Cancer Test
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App